Jim Simons Arvinas, Inc. Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q2 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Arvinas, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,214,355 shares of ARVN stock, worth $11.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,214,355

Previous 132,300 817.88%

Holding current value

$11.8 Million

Previous $928,000 863.04%

% of portfolio

0.01%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$6.07 - $9.62 $6.57 Million - $10.4 Million	1,082,055 Added 817.88%	1,214,355 $8.94 Million
Q1 2025 May 14, 2025	BUY	$7.02 - $20.5 $445,068 - $1.3 Million	63,400 Added 92.02%	132,300 $928,000
Q4 2024 Feb 13, 2025	SELL	$17.83 - $28.04 $1.35 Million - $2.12 Million	-75,500 Reduced 52.29%	68,900 $1.32 Million
Q3 2024 Nov 13, 2024	SELL	$23.66 - $32.73 $3.1 Million - $4.29 Million	-131,000 Reduced 47.57%	144,400 $3.56 Million
Q2 2024 Aug 09, 2024	SELL	$24.46 - $40.4 $2.12 Million - $3.5 Million	-86,573 Reduced 23.92%	275,400 $7.33 Million
Q1 2024 May 13, 2024	BUY	$36.38 - $52.31 $4.53 Million - $6.51 Million	124,400 Added 52.36%	361,973 $14.9 Million
Q4 2023 Feb 13, 2024	BUY	$14.19 - $42.33 $1.76 Million - $5.24 Million	123,873 Added 108.95%	237,573 $9.78 Million
Q3 2023 Nov 14, 2023	SELL	$19.64 - $28.21 $547,956 - $787,059	-27,900 Reduced 19.7%	113,700 $2.23 Million
Q2 2023 Aug 11, 2023	BUY	$21.73 - $31.43 $2.01 Million - $2.91 Million	92,700 Added 189.57%	141,600 $3.52 Million
Q1 2023 May 12, 2023	BUY	$26.15 - $37.26 $1.28 Million - $1.82 Million	48,900 New	48,900 $1.34 Million
Q2 2022 Aug 12, 2022	SELL	$36.01 - $74.24 $4.05 Million - $8.34 Million	-112,400 Reduced 86.2%	18,000 $758,000
Q1 2022 May 13, 2022	SELL	$60.27 - $81.57 $385,728 - $522,047	-6,400 Reduced 4.68%	130,400 $8.78 Million
Q4 2021 Feb 11, 2022	BUY	$65.85 - $96.21 $3.54 Million - $5.18 Million	53,800 Added 64.82%	136,800 $11.2 Million
Q3 2021 Nov 12, 2021	SELL	$73.2 - $107.87 $7.33 Million - $10.8 Million	-100,200 Reduced 54.69%	83,000 $6.82 Million
Q2 2021 Aug 13, 2021	SELL	$60.45 - $84.26 $2.98 Million - $4.15 Million	-49,300 Reduced 21.2%	183,200 $14.1 Million
Q1 2021 May 13, 2021	BUY	$58.19 - $91.37 $8.14 Million - $12.8 Million	139,900 Added 151.08%	232,500 $15.4 Million
Q4 2020 Feb 10, 2021	BUY	$20.19 - $84.93 $1.87 Million - $7.86 Million	92,600 New	92,600 $7.87 Million
Q3 2020 Nov 13, 2020	SELL	$22.99 - $36.34 $2.13 Million - $3.36 Million	-92,500 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$29.88 - $56.74 $3.82 Million - $7.26 Million	-127,995 Reduced 58.05%	92,500 $3.1 Million
Q1 2020 May 14, 2020	BUY	$33.0 - $54.5 $2.35 Million - $3.89 Million	71,295 Added 47.78%	220,495 $8.89 Million
Q4 2019 Feb 13, 2020	BUY	$15.39 - $44.38 $2.3 Million - $6.62 Million	149,200 New	149,200 $6.13 Million

Others Institutions Holding ARVN

# of Institutions

246

Shares Held

68.3M

Call Options Held

2.99M

Put Options Held

534K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $515M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account